Showing posts with label Alcohol. Show all posts
Showing posts with label Alcohol. Show all posts

Sunday, January 27, 2019

A round-up of happenings in medicine this week




Alcohol and the AF link: India is going through a new epidemic of atrial fibrillation (AF), which is linked to acute attacks of paralysis. Now a study published in the journal Heart Rhythm has shown that regular alcohol intake at moderate levels (8-21 drinks per week) is associated with electrical and structural changes in atrial myocardium.

Moderate alcohol consumption is an independent predictor of the atrial remodeling, characterized by significantly reduced atrial voltage and conduction velocities and increased atrial dimensions. The same was not found for mild alcohol intake levels, defined as two to seven drinks per week.

Screen all new cancer patients for hepatitis: A new study published online on January 17 in JAMA Oncology has found a large reservoir of patients with cancer and undiagnosed hepatitis virus infections and has suggested that all newly diagnosed cancer patients should be screened for hepatitis. They found that 6.5% had previously been infected with hepatitis B virus (HBV), 0.6% had chronic HBV infection, 2.4% had hepatitis C (HCV) infection, and 1.1% were infected with HIV.

Universal screening for HBV, HCV, and HIV infection is not routinely performed in patients diagnosed with cancer. Universal screening could prevent complications from hepatitis, such as liver failure and kidney disease. Immunosuppressive cancer drugs such as rituximab can cause some viruses to reactivate and multiply.

Valsartan and cancer: The US FDA said that some versions of the blood pressure-lowering drug valsartan contained trace amounts of a carcinogen for four years before regulators detected the impurity last summer, triggering a widespread recall of the tainted drugs.

FDA officials said the cancer risk for any person who took valsartan that had the carcinogen nitrosodimethylamine, or NDMA, is small. FDA scientists concluded there would be one more cancer case above average rates for every 8,000 people on the highest dose of valsartan for four years.

And now irbesartan has been recalled: In US, Prinston Pharmaceutical Inc has recalled one consumer-level lot of irbesartan and seven lots of irbesartan hydrochlorothiazide (HCTZ) tablets because of the presence of the probable carcinogen N-nitrosodiethylamine (NDEA), marking the latest recall of tainted sartan products produced in the United States.

This announcement on January 18, stems from the finding of NDEA in the active pharmaceutical ingredient (API) manufactured by China's Zhejiang Huahai Pharmaceuticals (ZHP), the company at the center of the tainted sartan crisis.

The recalled product was distributed nationwide to wholesale, distributor, repackager, and retail customers. It comes in 30- and 90-count bottles, with an expiration date of February 2021 for the one irbesartan lot and March 2021 for the seven irbesartan HCTZ lots.

A new sarcoma drug: Eli Lilly and Co.’s cancer drug Lartruvo should not be started in new patients, and those patients already taking it should ask their doctors if they should continue as a key study that failed to show the medicine prolonged lives. The drug was given accelerated approval by the US FDA in 2016 based on promising data from an early-stage study.



Dr KK Aggarwal
Padma Shri Awardee
President Elect Confederation of Medical Associations in Asia and Oceania   (CMAAO)
Group Editor-in-Chief IJCP Publications
President Heart Care Foundation of India
Past National President IMA


Monday, December 24, 2018

Screen your patients for anxiety and depression as a routine


Anxiety and depression are as strong predictors of various diseases such as high blood pressure, heart disease, arthritis, headaches, back pain and stomach upset as are obesity and smoking, according to the new research from the University of California San Francisco published online Dec. 17, 2018 in Health Psychology.

A population-based cohort study in the US analyzed data from more than 15,000 older adults enrolled in the Health and Retirement study over a four-year period and examined the longitudinal associations of anxiety and depression symptoms with onset of self-reported physical health indices. Baseline anxiety and depression were measured and tested as predictors of medical illness including heart disease, stroke, arthritis, high blood pressure, diabetes and cancer and somatic symptoms such as stomach issues, shortness of breath, dizziness, back pain, headache, pain and eyesight issues.

The study found that anxiety and depression not only predicted greater incidence of nearly all medical illnesses and somatic symptoms, they also independently increased risk for most physical health indices assessed. Overall, 16% of study participants had anxiety and depression symptoms, 31% were obese and 14% were current smokers.

·         Those with anxiety and depression symptoms were at 65% higher risk for a heart condition, 64% higher risk for stroke and 50% higher risk for hypertension.
·         Anxiety and depression also predicted greater incidence of most somatic symptoms, including headache, stomach upset, back pain and shortness of breath. Anxious and depressed patients had 161% increased risk of headache.

In a patient of heart disease or hypertension or back pain, for instance, the questions when eliciting history, usually relate to risk factors like smoking, alcohol, unhealthy diet, sedentary life or trauma etc. And, accordingly, lifestyle modifications and/or pharmacological management of risk factors, if present, are advised.

But, this approach may be overlooking two significant factors - anxiety and depression - as this study elucidates. The observed effects of anxiety and depression were found to be as strong as or even more powerful than those of obesity and smoking.

Hence, it is important to routinely screen patients for anxiety and depression. The presenting symptoms may not be just due to a physical illness, but may be due to an underlying mental health disorder such as anxiety and depression.


Dr KK Aggarwal
Padma Shri Awardee
President Elect Confederation of Medical Associations in Asia and Oceania   (CMAAO)
Group Editor-in-Chief IJCP Publications
President Heart Care Foundation of India
Immediate Past National President IMA


Saturday, August 13, 2011

#AskDrKK: How to avoid getting leg clots while on board with flights longer than six to eight hours

#DrKKAnswers:
1. Stand up and walk around every 1-2 hours
2. Do not smoke prior to travel
3. Wear loose-fitting, comfortable clothing
4. Prefer bulkhead or emergency row seating
5. Periodically flex and extend the ankles and knees
6. Do not cross the legs
7. While seated change positions frequently
8. Avoid dehydration by drinking plenty of non-alcoholic beverages
9. Wear knee-high compression stockings
10.Avoid sedatives and sleeping pills and alcohol, which could impair the ability to get up and move around.


Tuesday, July 26, 2011

Dr K K Abswers: Moderate vs Heavy vs Binge Drinking

Moderate drinking: low risk for alcohol problems
  • Women: <2 US drinks per day
  • Men: <3 US drinks per day
  • People age ≥65: < US 2 drinks per day
Heavy drinking: at risk for alcohol problems
  • Women: >7 US drinks per week or 3 drinks per occasion
  • Men: >14 US drinks per week or 4 drinks per occasion
Binge drinking
  • Women: 4 or more US drinks in a row
  • Men: 5 or more US drinks in a row

Dr KK Answers: What is one drink?

What is a standard drink?
For different countries, a standard drink is generally considered as follows
1.       United States: 14 to 15 g alcohol (0.5 to 0.6 fl oz), equivalent to 12 oz (360 ml) beer, 5 oz wine (150 ml), and 1.5 oz (45 ml) of 80 proof liquor.
  1. Great Britain: 8 g alcohol or app 24 ml 80 proof liquor. 
  2. Japan: 19.75 g alcohol ( app. 60 ml 80 proof liquor. )
  3. India 10 grams or app. 30 ml of 80 proof liquor
  4. Patiala peg India: 20 grams of alcohol or app. 60 ml 80 proof liquor. .
(Formula 1 ml = 0.8 grams of alcohol)

Do not consume more than 18 ml alcohol per day

Diseases like coronary heart blockages, ischemic paralysis and diabetes, that moderate alcohol intake prevents, are the diseases of the elderly, men, and people with coronary heart disease risk factors. Only in this group moderate alcohol consumption is associated with a substantial mortality benefit relative to abstention or limited drinking.
 For young to middle aged adults, especially women, moderate alcohol consumption can increase the risk of the most common causes of death such as trauma and breast cancer.
Women drinkers should take folate supplement to reduce the risk of breast cancer.
Younger men under age 45 experience more harm than benefit from alcohol consumption. In them moderate alcohol use is unlikely to provide any mortality benefit. However if no contraindication consumption of less than one drink a day is safe provided they are not in a job of operation of dangerous equipment.
In patients with established contraindications to alcohol use, even this level of alcohol use is dangerous. For them no level of alcohol consumption is safe. These people include pregnant ladies, personal or strong family history of alcoholism, past hemorrhagic paralysis, liver or pancreatic disease and operation of potentially dangerous equipment or machinery. There are some who can take but under a limit and they are if they have active gastritis, esophagitis, premalignant gastrointestinal lesions such as Barrett's esophagus, or a strong family history of breast cancer.
Men can tolerate more alcohol than women.  The ideal safe “medicinal dose” of alcohol for men is 6 grams per day (app. 18 ml 80 proof whisky) or one drink taken every other day, in whom not contraindicated.  The dose associated with lowest mortality in woman is 4 gm/day (One drink every 4th day).
Medicinal safe dose is different from safe dose in absence of contraindications. The safe limit is no more than two drinks (each drink id 45 ml of 80 proof whisky) daily for men and one drink daily for women.

Monday, July 18, 2011

Dr KK Answers: What is the link between alcohol and blood pressure?

One should limit consumption to no more than two drinks (1 oz or 30 ml ethanol; e.g., 24 oz beer, 10 oz wine, or 3 oz 80-proof whiskey) per day in most men and to no more than one drink per day in women and lighter weight persons. It can alone reduce blood pressure by 2-4 mmHg.